The global Epharmcy Market, much like the global e-retail industry, has seen the entry of a large number of players in developed as well as developing economies with high-speed and consistent internet connections and a large consumer base of smart computing devices, observes Transparency Market Research in a recent report. The market is strictly regulated in developed economies across North America and Europe, wherein ePharmacies are registered with a central drug enforcement or advisory authority and are required to conform to specific norms, with only lawfully registered pharmacies allowed to sell drugs. Owing to the vast growth potential displayed by the market, several retail pharmacists in these regions are partnering with online portals to establish their ePharmacies.
In a number of developing economies, however, many rogue ePharmacies have mushroomed over the years and drug enforcement authorities are taking major steps to make the ePharmacy marketplace more regulated. Developments in this direction will put a rein on the rapidly rising numbers of ePharmacies, especially in regions such as Asia Pacific and Latin America. These regions are also the ones with the most promising growth opportunities owing to the presence of high-speed internet connectivity and a large consumer base of mobile computing device users. Thus companies in the relatively novel marketplace could find promising growth opportunities in these regions as the ePharmacy market becomes more regulated.
Transparency Market Research estimates that the global ePharmacy market will exhibit an impressive CAGR of 17.5% over the period between 2015 and 2023, taking a massive leap from a valuation of US$29.35 bn in 2014 to an opportunity of US$128.02 bn by 2023.
Request to View Brochure of Report –
From a geographical standpoint, the ePharmacy market in North America is presently the leading contributor of revenue to the global market. The region accounted for a nearly 37% of the global market in 2014, followed by Europe. Over the report’s forecast period, however, Europe is projected to lead the way, outpacing North America in terms of revenue generation. The market in Asia Pacific is expected to remain filled with promising growth opportunities and become more regulated over the forecast period. Emerging economies such as China and India and developed ones including Japan and South Korea will be at the forefront of development of the Asia Pacific ePharmacy market over the report’s forecast period.